Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Colorectal Neoplasms and PIK3R1[original query] |
|---|
| Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Feb 14 (3): 633-7. Li Li, Plummer Sarah J, Thompson Cheryl L, Tucker Thomas C, Casey Grah |
| PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer. Clinical colorectal cancer 2012 Jun 11 (2): 143-50. Sood Arjun, McClain Danielle, Maitra Radhashree, Basu-Mallick Atrayee, Seetharam Raviraja, Kaubisch Andreas, Rajdev Lakshmi, Mariadason John M, Tanaka Kathryn, Goel Sanj |
| EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Sep 39 (9): 1010428317724517. Alvarez Karin, Orellana Paulina, Villarroel Cynthia, Contreras Luis, Kawachi Hiroshi, Kobayashi Maki, Wielandt Ana Maria, De la Fuente Marjorie, Triviño Juan Carlos, Kronberg Udo, Carvallo Pilar, López-Köstner Francis |
| Genome-wide network-based pathway analysis of CSF t-tau/Aß1-42 ratio in the ADNI cohort. BMC genomics 2017 May 18 (1): 421. Cong Wang, Meng Xianglian, Li Jin, Zhang Qiushi, Chen Feng, Liu Wenjie, Wang Ying, Cheng Sipu, Yao Xiaohui, Yan Jingwen, Kim Sungeun, Saykin Andrew J, Liang Hong, Shen Li, |
| Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors. Therapeutic advances in medical oncology 2022 6 14 17588359221105022. Xu Ting, Wang Xicheng, Wang Zhenghang, Deng Ting, Qi Changsong, Liu Dan, Li Yanyan, Ji Congcong, Li Jian, Shen L |
| Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2025 1 1-13. Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G White, John Paul Shen, Eduardo Vilar, Christine Parseghian, Arvind Dasari, Van Karlyle Morris, Ryan Huey, Michael J Overman, Robert Wolff, Kanwal P Raghav, Jason Willis, Kristin Alfaro, Andy Futreal, Y Nancy You, Scott Kope |
- Page last reviewed:Feb 1, 2024
- Content source:

